Updated
CVS HealthCVS · Healthcare
$83.85+3.10%
Market cap$107.3B
IndustryHealthcare Plans
CVS Health (CVS) Superinvestor holders
42 of the superinvestors we track hold CVS Health (CVS) in their latest 13F filings, $12.5B in total.
Summary
The largest holder is Dodge & Cox, with $5.2B, 2.7% of the portfolio.
In their latest quarter: 3 opened a new position, 12 added, 24 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Dodge & Cox | Trimmed | 50,012,765 | $5.2B | 2.7% | Q2 2026 |
| Christopher Davis Davis Selected Advisers |
Trimmed | 11,865,916 | $1.2B | 5.3% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 8,536,952 | $883M | 0.7% | Q2 2026 |
| Richard Pzena Pzena Investment Management |
Trimmed | 10,296,903 | $882M | 2.6% | Q3 2026 |
| Arrowstreet Capital | Trimmed | 5,069,263 | $524M | 0.2% | Q2 2026 |
| Larry Robbins Glenview Capital Management |
Trimmed | 4,824,799 | $499M | 10.0% | Q2 2026 |
| Josef Lakonishok LSV Asset Management |
Trimmed | 4,455,620 | $382M | 0.7% | Q3 2026 |
| Andreas Halvorsen Viking Global Investors |
New position | 3,663,361 | $379M | 1.1% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 3,001,684 | $311M | 0.7% | Q2 2026 |
| Prem Watsa Fairfax Financial Holdings |
Held | 2,712,000 | $281M | 10.6% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 2,411,937 | $249M | 0.1% | Q2 2026 |
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | 2,385,490 | $247M | 0.1% | Q2 2026 |
| Mark Donovan Boston Partners |
Added | 2,033,583 | $210M | 0.2% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
New position | 1,961,032 | $203M | 0.3% | Q2 2026 |
| Charles Brandes Brandes Investment Partners, LP |
Trimmed | 1,674,319 | $173M | 1.2% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 1,382,037 | $143M | 0.1% | Q2 2026 |
| Jennison Associates | Added | 942,869 | $98M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 758,947 | $79M | 0.1% | Q2 2026 |
| John Rogers Ariel Investments |
Added | 730,110 | $76M | 0.8% | Q2 2026 |
| Jeremy Grantham GMO |
Trimmed | 541,115 | $56M | 0.1% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 464,885 | $48M | 0.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Added | 441,016 | $46M | 0.1% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 440,972 | $46M | 0.2% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 370,000 | $38M | 0.2% | Q2 2026 |
| Bill Nygren Harris Associates LP |
Trimmed | 335,817 | $35M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 394,189 | $34M | 0.0% | Q3 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 325,000 | $34M | 0.0% | Q2 2026 |
| Bernard Horn Polaris Capital Management |
Trimmed | 345,600 | $30M | 3.1% | Q3 2026 |
| Man Group Man Group plc |
Trimmed | 226,395 | $23M | 0.0% | Q2 2026 |
| Tony Yoseloff Davidson Kempner Capital Management |
Added | 226,036 | $23M | 0.6% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Added | 93,718 | $10M | 0.1% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 97,886 | $8M | 0.0% | Q3 2026 |
| Neil Hennessy Hennessy Advisors |
Held | 72,100 | $6M | 0.2% | Q3 2026 |
| Alan Howard Brevan Howard |
Trimmed | 51,694 | $5M | 0.1% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 36,168 | $4M | 0.0% | Q2 2026 |
| Robert Olstein Olstein Capital Management |
Trimmed | 50,000 | $4M | 0.8% | Q1 2026 |
| Alger Fred Alger Management |
New position | 26,479 | $3M | 0.0% | Q2 2026 |
| Mark Boyar Boyar Asset Management |
Trimmed | 15,917 | $1M | 0.8% | Q3 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 7,070 | $731,391 | 0.0% | Q2 2026 |
| David Katz Matrix Asset Advisors |
Held | 6,175 | $529,136 | 0.0% | Q3 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 3,825 | $395,660 | 0.0% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Added | 1,381 | $142,864 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 41 |
| Q1 2026 | 43 |
| Q4 2025 | 46 |
| Q3 2025 | 48 |
| Q2 2025 | 44 |
| Q1 2025 | 44 |
| Q4 2024 | 45 |
| Q3 2024 | 42 |
Questions about CVS Health
Which superinvestors own CVS Health?
42 of the superinvestors we track hold CVS Health (CVS) in their latest 13F filings, $12.5B in total. Dodge & Cox, Christopher Davis, Hersh Cohen, Richard Pzena, Arrowstreet Capital, Larry Robbins.
Who is the largest superinvestor holder of CVS?
The largest holder is Dodge & Cox, with $5.2B, 2.7% of the portfolio.
From CVS Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.